knowledge -WSS

knowledge

author：entertainment 2025-09-30 18:58:39 - browse：62931

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Blood tests recalled over risk of missed heart attack diagnosis

leisure time

WSS

Digital health: a case of mistaken identity

Grail faces three suits alleging harassment, retaliation

Federal judge rules Oregon’s tough new gun law is constitutional

Federal judge rules Oregon’s tough new gun law is constitutional

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Listen: A conversation with researcher Kevin Esvelt on biosecurity

explore

knowledge

leisure time

Medicare details structure of new drug price negotiation program

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Tori Bowie and the unacceptable rates of Black maternal death

ASCO eve: Let’s set the table for this year's meeting

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

H5N1 bird flu outbreak: Second human case reported, in Michigan

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Europe sees delivery challenges ahead on Alzheimer's therapies

Wikipedia

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

H5N1 virus can be tracked in retail milk, scientists say

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Fentanyl is making it harder to start addiction treatment

Bird flu surveillance in wastewater gets boost from consortium

focus

leisure time

knowledge

focus